Artwork

Content provided by Axios. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Axios or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Biotech investor Bob Nelsen on AstraZeneca and his plan to revolutionize pharma

15:00
 
Share
 

Manage episode 278399360 series 2826627
Content provided by Axios. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Axios or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

AstraZeneca and the University of Oxford today reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and which may be distributed earlier in developing countries. Dan digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who today launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.

Plus, Axios health care editor Sam Baker joins to discuss AstraZeneca’s interim analysis.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

750 episodes

Artwork
iconShare
 
Manage episode 278399360 series 2826627
Content provided by Axios. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Axios or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

AstraZeneca and the University of Oxford today reported promising efficacy data for their COVID-19 vaccine, which has less stringent storage requirements than the Pfizer and Moderna vaccines and which may be distributed earlier in developing countries. Dan digs into the state of vaccine and therapeutics manufacturing with Bob Nelsen, a successful biotech investor who today launched Resilience, a giant new pharma production platform that he believes will prepare America for its next major health challenges.

Plus, Axios health care editor Sam Baker joins to discuss AstraZeneca’s interim analysis.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

750 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide